CLINICAL RESEARCH POSTER PRESENTATION ABSTRACTS
Please note: All posters will be displayed in Salons 10-12.

FRIDAY, 5:45-6:30 PM


Elsas SM, Sung S, Randall-Stitt CA, White G.

A mind-body approach to epilepsy renders first study patient seizure free.

Oregon Health and Science University elsas@ohsu.edu

PURPOSE: We report on the first patient in a pilot study of a mind-body treatment approach for epileptic seizures.

METHODS: The patient is a 47 year old woman with complex partial and generalized tonic clonic seizures since age 17. Her EEG shows frequent spike and slow wave epileptiform discharges with a bilateral frontal predominance and occasional left and right parietal epileptiform sharp waves. Her probability of nonepileptic seizures, calculated from the MMPI2 score, EEG data and duration of seizure disorder, was 0.0031. The mind-body treatment consisted of daily meditative relaxation, weekly counseling to identify physical and emotional seizure triggers, and the use of meditative relaxation to interrupt seizures in the aura stage. Anticonvulsant medication was continued without change.

RESULTS: From a baseline frequency of 16 seizures per month the patient has now been seizure free for more than 4 months. Average monthly frequency of all seizure types, overall quality of life in epilepsy (QOLIE-89) scores, and Profile of Mood States (POMS) scores are given in the table below for 4 time points in the study: the end of a 4 month period preceding study enrollment, the end of a 3 month baseline observation period, the end of the 6 month treatment period, and 4 months of observation after completion of treatment.

  Pre-baseline
(4 mo)
Baseline
(3 mo)
Treatment period
(6 mo)
Post-treatment
(4 mo)
Avg seizure freq / month 16.3 9.5 1.3 0.0
Overall QOLIE score
(6.4-69.6)
28.9 34.2 46.4 Not yet obtained
POMS total mood disturbance 80 94 37
POMS tension/anxiety 25 26 8
POMS confusion/bewilderment 8 7 0

CONCLUSIONS: The mind-body approach examined using meditative relaxation and counseling appears promising and a randomized controlled trial is in preparation.

 

Back